May 7, 2026
Research Peptides vs. Supplement Peptides: Where the Regulatory Line Gets Drawn

The peptide market sits at a crossroads that regulators, payment processors, and financial institutions are closely watching. A product marketed as a dietary supplement and the same compound sold for "research use only" may contain identical molecules — but they exist in entirely different regulatory worlds, and the consequences of misclassifying one as the other […]

Read More
December 3, 2025
US Functional Mushroom Industry Forms Council to Address Quality Standards and Testing Gaps

Leading mushroom growers, suppliers, and brands formed the Functional Mushroom Council (FMC), a nonprofit coalition that addresses quality concerns and establishes unified standards in North America's rapidly expanding functional mushroom market. The industry, which surpassed $1.6 billion in 2023, is projected to reach $2.2 billion by year-end while confronting consumer watchdog questions about efficacy claims […]

Read More
December 2, 2025
ESMA's Product Supplement Guidelines: New Restrictions on Security Modifications

The European Securities and Markets Authority released a Consultation Paper on February 18, 2025, proposing draft guidelines that fundamentally restrict how issuers can modify base prospectuses through supplements. The guidelines respond to Article 23(8) of the Prospectus Regulation, which mandates that the ESMA specify the circumstances in which supplements introduce new security types not already […]

Read More
November 24, 2025
New Research Explores Cannabis as Tool to Reduce Alcohol Consumption

In a groundbreaking study published this week in the American Journal of Psychiatry, researchers at Brown University have provided some of the strongest evidence yet that cannabis use may significantly reduce alcohol consumption in the short term. The findings arrive at a critical moment as public health officials grapple with both rising cannabis use and […]

Read More
November 24, 2025
Botanical Supplements Market Set to Surge with 10.3% CAGR, Reaching $145.16 Billion by 2034

The global botanical supplements market is poised for dramatic expansion over the next decade, according to new research from Precedence Research and its sister firm Towards FnB. The market, valued at $54.46 billion in 2024, is projected to reach $145.16 billion by 2034, representing a compound annual growth rate of 10.3% from 2025 to 2034. […]

Read More
November 13, 2025
Europe’s Functional Mushroom Market Set to Surpass $28.6 Billion by 2032

Europe’s functional mushroom market is entering a period of rapid expansion, projected to reach USD 28.67 billion by 2032, according to a new report from DataM Intelligence. Growing at a CAGR of 11.09% between 2025 and 2032, the market’s growth reflects Europe’s surging interest in natural wellness, plant-based nutrition, and evidence-backed adaptogenic ingredients. Regulatory and […]

Read More
November 5, 2025
Collagen Peptides Show Promise as Anti-Obesity Supplement in Animal Research

A comprehensive systematic review and meta-analysis reveals that collagen peptide supplementation produces significant anti-obesity effects in rodent models. The research, analyzing 21 studies involving 339 animals, demonstrates meaningful improvements across multiple metabolic markers when animals consumed collagen peptides for at least three weeks. Substantial Body Weight and Food Intake Reductions The meta-analysis documented significant decreases […]

Read More
November 5, 2025
Peptide Synthesis Market Poised for Explosive Growth Through 2033

The global peptide synthesis market is experiencing dramatic expansion as pharmaceutical companies and research institutions accelerate investment in peptide-based therapeutics. Industry analysts project the market will nearly triple from $861 million in 2024 to $2.3 billion by 2033, representing an 11.4% compound annual growth rate. Major Manufacturing Capacity Expansions Signal Industry Confidence Recent capital investments […]

Read More
November 5, 2025
Cyanobacteria Study Reveals Hidden Protein Functions Through Small Peptide Discovery

A comprehensive genomic and proteomic study has identified previously unknown small proteins in five species of cyanobacteria. The research reveals that small open reading frame-encoded peptides play essential roles in photosynthesis, metabolism, stress responses, and cellular defense systems. Small Proteins With Big Functions Small open reading frames and their encoded peptides represent an emerging frontier […]

Read More
November 4, 2025
Alzheimer's Patients Show Cognitive Improvements in Longest Clinical Cannabis Trial

A groundbreaking clinical trial demonstrates that plant-derived cannabis extracts can improve cognitive function in patients with Alzheimer's disease-associated dementia. The 26-week placebo-controlled study represents the longest clinical investigation ever conducted on cannabis effects in this patient population. Study Design and Patient Outcomes An international research team from Brazil and the United States enrolled 28 patients […]

Read More
1 2
crossmenu